IRIS
LEPEDDA, Antonio Junior
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.127
AS - Asia 2.331
SA - Sud America 1.505
EU - Europa 1.442
AF - Africa 80
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 9
Totale 9.510
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.032
BR - Brasile 1.360
SG - Singapore 961
CN - Cina 759
UA - Ucraina 528
IT - Italia 267
HK - Hong Kong 243
DE - Germania 200
FI - Finlandia 91
FR - Francia 85
VN - Vietnam 79
GB - Regno Unito 70
SE - Svezia 65
AR - Argentina 58
TR - Turchia 55
CA - Canada 41
IQ - Iraq 36
EC - Ecuador 30
MX - Messico 30
ZA - Sudafrica 30
IN - India 25
RU - Federazione Russa 25
BD - Bangladesh 24
PK - Pakistan 22
UZ - Uzbekistan 19
KR - Corea 18
MA - Marocco 18
BE - Belgio 16
PL - Polonia 16
NL - Olanda 14
EU - Europa 13
JP - Giappone 13
VE - Venezuela 11
NP - Nepal 10
PE - Perù 10
CO - Colombia 9
GR - Grecia 9
ID - Indonesia 9
PY - Paraguay 9
AU - Australia 8
ES - Italia 8
AE - Emirati Arabi Uniti 7
BO - Bolivia 7
DK - Danimarca 7
KE - Kenya 7
CL - Cile 6
CZ - Repubblica Ceca 6
DZ - Algeria 6
TN - Tunisia 6
AT - Austria 5
CR - Costa Rica 5
UY - Uruguay 5
AL - Albania 4
JM - Giamaica 4
KG - Kirghizistan 4
KZ - Kazakistan 4
LT - Lituania 4
PH - Filippine 4
AZ - Azerbaigian 3
CI - Costa d'Avorio 3
GT - Guatemala 3
IL - Israele 3
IR - Iran 3
JO - Giordania 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
CG - Congo 2
DO - Repubblica Dominicana 2
EG - Egitto 2
GE - Georgia 2
HN - Honduras 2
HR - Croazia 2
KW - Kuwait 2
LU - Lussemburgo 2
MD - Moldavia 2
MY - Malesia 2
NI - Nicaragua 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
RO - Romania 2
SA - Arabia Saudita 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BH - Bahrain 1
BW - Botswana 1
CH - Svizzera 1
CY - Cipro 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
HU - Ungheria 1
IE - Irlanda 1
IM - Isola di Man 1
Totale 9.495
Salva come PNG Salva come JPEG
Città #
Dallas 1.462
Chandler 559
Singapore 521
Jacksonville 322
Hong Kong 243
Princeton 174
Beijing 163
New York 145
Ashburn 140
Nanjing 133
Sassari 123
São Paulo 107
Ann Arbor 82
Wilmington 79
Dearborn 69
Nanchang 59
Shanghai 56
Rio de Janeiro 48
Los Angeles 46
Boardman 44
Santa Clara 38
Belo Horizonte 37
Tianjin 34
Changsha 32
Shenyang 32
Ho Chi Minh City 30
Hebei 29
Woodbridge 28
Curitiba 26
Izmir 26
Campinas 23
Jiaxing 21
Baghdad 20
Porto Alegre 20
Johannesburg 19
Buffalo 18
Seoul 18
Tashkent 18
Brussels 16
Kunming 16
San Francisco 16
Toronto 16
Warsaw 16
Zhengzhou 16
Brasília 15
Denver 14
Hangzhou 14
Mountain View 14
Salvador 14
Andover 13
Goiânia 13
Guarulhos 13
London 13
Montreal 13
Ningbo 13
Orem 13
Ribeirão Preto 13
Stockholm 13
Villiers-sur-marne 13
Guayaquil 12
Norwalk 12
Tokyo 12
Fortaleza 11
Hanoi 11
Jinan 11
Manaus 11
Atlanta 10
Guangzhou 10
Phoenix 10
Sorocaba 10
Ankara 9
Bauru 9
Blumenau 9
Brooklyn 9
Dhaka 9
Munich 9
Quito 9
Recife 9
Santo André 9
Taubaté 9
Amsterdam 8
Boston 8
Campo Grande 8
Casablanca 8
Chennai 8
Columbus 8
Council Bluffs 8
Helsinki 8
Juiz de Fora 8
Osasco 8
Poplar 8
Bragança Paulista 7
Florianópolis 7
Houston 7
Istanbul 7
Lima 7
Limeira 7
Maceió 7
Mauá 7
Mexico City 7
Totale 5.702
Salva come PNG Salva come JPEG
Nome #
A novel LIF-CE method for the separation of hyaluronan- and chondroitin sulfate-derived disaccharides: Application to structural and quantitative analyses of human plasma low- and high-charged chondroitin sulfate isomers 203
A proteomic approach to differentiate histologically classified stable and unstable plaques from human carotid arteries. IF 2009: 4.522 JCR: Q1 180
A poly-L-lactic acid/ collagen/glycosaminoglycan matrix for tissue engineering applications 170
Apolipoprotein Profiles in Atherosclerotic Disease 160
Natural collagenic skeleton of marine sponges in pharmaceutics: Innovative biomaterial for topical drug delivery 156
Apolipoprotein profiles in atherosclerotic disease 152
Identification of differentially expressed plasma proteins in atherosclerotic patients with type 2 diabetes 149
Association between human plasma chondroitin sulphate isomers and carotid atherosclerotic plaque 144
Applications of two-dimensional electrophoresis technology to the study of atherosclerosis 144
Molecular Characterization of Plasma HDL, LDL, and VLDL Lipids Cargos from Atherosclerotic Patients with Advanced Carotid Lesions: A Preliminary Report 142
Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-g (MIG) 139
Evaluation of Early Markers of Nephropathy in Patients with Type 2 Diabetes Mellitus 137
Apolipoprotein Profiles in Atherosclerotic Disease 136
Content and distribution of glycosaminoglycans/proteoglycans in human thoracic aortic aneurysm 136
Analysis of changes in tyrosine and serine phosphorylation of red cell membrane proteins induced by P. falciparum growth 135
Human serum albumin Cys34 oxidative modifications following infiltration in the carotid atherosclerotic plaque 135
Differential proteomic analysis of human atherosclerotic plaque extracts 133
Gradients in pore size enhance the osteogenic differentiation of human mesenchymal stromal cells in three-dimensional scaffolds 132
Short-end injection capillary electrophoresis for quantification of plasma chondroitin sulfate isomer disaccharides 128
Apolipoprotein profiles in atherosclerotic disease 126
A Method for Urinary Trypsin Inhibitor (UTI) Purification Combining Anion-Exchange Chromatography Enrichment and Preparative SDS-PAGE 123
Evaluation of human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 121
Glycosaminoglycan and transforming growth factor beta 1 changes in human plasma and urine during the menstrual cycle, in vitro fertilization treatment, and pregnancy 120
A Collagen-GAG synthetic extracellular matrix entrapped into PLLA polymeric scaffolds. 120
IDENTIFICATION OF POTENTIAL BIOMARKERS IN MYASTHENIA GRAVIS DISEASE BY PLASMA PROTEOMIC ANALYSIS 119
Evaluation of plasma glycosaminoglycans levels and structure in patients undergoing carotid endarterectomy 118
Differential distribution of structural components and hydration in aortic and pulmonary heart valve conduits: Impact of detergent-based cell removal. IF 2010: 4.824 JCR: Q1 118
A proteomic approach to identify circulating or tissue biomarkers of atherosclerosis 117
Development of a method for urine bikunin/urinary trypsin inhibitor (UTI) quantitation and structural characterization: Application to type 1 and type 2 diabetes 116
Levels of Urinary Trypsin Inhibitor and Structure of Its Chondroitin Sulphate Moiety in Type 1 and Type 2 Diabetes 115
Glycosaminoglycan functionalization of electrospun scaffolds enhances Schwann cell activity 115
Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-γ (MIG). 115
Impact of first trimester fasting glycemic levels on expression of proteoglycans in pregnancy 113
Evaluation of human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 112
Evaluation of plasma glycosaminoglycans levels and structure in patients undergoingcarotid endarterectomy 107
Plasma vitronectin is reduced in patients with myasthenia gravis: Diagnostic and pathophysiological potential 107
Proteomic analysis of plasma apolipoproteins in relation to atherosclerosis 107
Identification and characterization of biomarkers in atherosclerosis and diabetes. 106
Apolipoprotein signature of hdl and ldl from atherosclerotic patients in relation with carotid plaque typology: A preliminary report 105
Significance of urinary glycosaminoglycans/proteoglycans in the evaluation of type 1 and type 2 diabetes complications 103
Tuning Cell Differentiation into a 3D Scaffold Presenting a Pore Shape Gradient for Osteochondral Regeneration 103
Marine-derived sulfated polysaccharides enhance hemocompatibility and endothelialization of nanofibrous PCL for vascular graft applications 102
Glycosaminoglycan and transforming growth factor beta1 changes in human plasma and urine during the menstrual cycle, in vitro fertilization treatment, and pregnancy. IF 2009: 3.970 JCR: Q1 100
Proteomic analysis of plasma-purified VLDL, LDL, and HDL fractions from atherosclerotic patients undergoing carotid endarterectomy: identification of Serum Amyloid A as a potential marker 97
Plasma PP13, urinary GAGs/PGs as early markers of pre-eclampsia 96
Protein sulfhydryl-group oxidation in stable and unstable human carotid plaques 94
Influencing chondrogenic differentiation of human mesenchymal stromal cells in scaffolds displaying a structural gradient in pore size 93
Structural analisys of plasma glycosaminoglycans in patients with atheromatous lesions 93
Urine bikunin as a marker of renal impairment in Fabry's disease 92
Protein oxidation in unstable plaque extracts from human carotid segments 91
GAG content and distribution in porcine aortic valve tissue and in acellular pericardium scaffolds from three mammal species 91
QUANTITATIVE AND STRUCTURAL ANALYSES OF URINARY TRYPSIN INHIBITOR IN TYPE 1 AND TYPE 2 DIABETES 91
Circulating Heparan Sulfate Proteoglycans as Biomarkers in Health and Disease 91
Urine Bikunin Quantitation and Structural Characterization in Type I and Type II Diabetes Patients 89
Urinary trypsin inhibitor is a marker of renal disease in Fabry’s patients. 88
Glycosaminoglycan content and distribution in human normal and varicose veins 86
Role of the small proteoglycan bikunin in human reproduction 86
Oxidative Modifications in Advanced Atherosclerotic Plaques: A Focus on In Situ Protein Sulfhydryl Group Oxidation 85
New Capillary Zone Electrophoresis (CZE) method for glycosaminoglycan analysis 85
Deciphering Acute Coronary Syndromes Pathobiology Through Proteomics 83
Protein sulfhydryl-groups oxidation in stable and unstable human carotid plaques 82
Overview of Current Proteomic Approaches for Discovery of Vascular Biomarkers of Atherosclerosis 81
Sequence variability of apolipoprotein E gene in Corsico-Sardinian ovines 80
Structural analysis of glycosaminoglycans from fresh and decellularized porcine aortic and pulmonary valves 79
Structural analysis of glycosaminoglycans from fresh and decellularized porcine aortic and pulmonary valves 79
Protein sulfhydryl group oxidation and mixed-disulfide modifications in stable and unstable human carotid plaques 77
Structural analysis of glycosaminoglycans and proteoglycans from fresh porcine aortic valves 77
Structural analysis of glycosaminoglycans from fresh and decellularized porcine aortic and pulmonary valves 77
Evidence for a pro-oxidant environment in atherosclerotic plaques from human carotid segments 76
Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-ϒ (MIG) 76
Plasma levels of C-reactive protein, leptin and glycosaminoglycans during spontaneous menstrual cycle: differences between ovulatory and anovulatory cycles 74
GLYCOSAMINOGLYCAN DIVERSITY IN MARINE SPONGE EXTRACELLULAR MATRIX 73
Proteomic study of differential protein expression in stable and unstable human atherosclerotic plaque 71
Circulating Proteoglycans/Glycosaminoglycans as Cancer Biomarkers 71
Structural analysis of glycosaminoglycans from fresh porcine aortic valves 70
Glycosaminoglycan diversity in marine sponge extracellular matrix 70
Fine structure of glycosaminoglycans from fresh and decellularized porcine cardiac valves and pericardium 70
Effects of Acidic Polysaccharide-Enriched Extracts from Holothuria tubulosa on Two- and Three-Dimensional Invasive Breast Cancer Cell Models 69
Urinary trypsin inhibitor is a marker of renal disease in Fabry’s patients 69
Human serum albumin Cys34 oxidative modifications after infiltration in the carotid atherosclerotic plaque 68
Glycosaminoglycans: From Vascular Physiology to Tissue Engineering Applications 68
Ultrasensitive Capillary Zone Electrophoresis (CZE) for glycosaminoglycan analisys in normal human plasma 68
Glycosaminoglycans and fabry’s disease 68
Proteomic analysis of plasma-purified VLDL, LDL and HDL fractions from atherosclerotic patients undergoing carotid endarterectomy: identification of Serum Amyloid A as a potential marker 68
Morphological and biochemical traits of target marine sponges 67
Proteomic study of differential protein expression in stable and unstable human atherosclerotic plaque 65
Proteomic analysis of differential protein expression and post-translational modifications in human atherosclerotic plaques 64
Plasma Levels of C-Reactive Protein, Leptin and Glycosaminoglycans During Spontaneous Menstrual Cycle: Differences Between Ovulatory and Anovulatory Cycles 64
Structural analysis of plasma glycosaminoglycans in patients undergoing carotid endarterectomy 61
Human serum albumin Cys34 oxidative modifications following infiltration in the carotid atherosclerotic plaque 61
Structural analysis of glycosaminoglycans from fresh porcine aortic valves 61
Evaluation of human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 61
Purification of an Acidic Polysaccharide with Anticoagulant Activity from the Marine Sponge Sarcotragus spinosulus 60
Human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 59
Molecular and pathobiological insights of bikunin/UTI in cancer 54
Searching for Atherosclerosis Biomarkers by Proteomics: A Focus on Lesion Pathogenesis and Vulnerability 53
Urine bikunin and kidney involvement in Fabry disease 40
Totale 9.581
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.441
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.441
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021330 0 0 0 0 0 13 84 4 110 93 16 10
2021/2022477 53 3 3 11 10 2 25 31 63 34 56 186
2022/2023996 94 82 10 185 112 157 0 122 163 13 40 18
2023/2024359 49 25 7 12 83 76 14 8 9 11 36 29
2024/20252.733 19 23 155 43 114 67 205 464 969 454 155 65
2025/20262.976 178 916 768 605 461 48 0 0 0 0 0 0
Totale 9.581